Strattera Side Effects May Result In Suicide Lawsuits
Strattera Side Effects Increase Suicidal Thoughts. Eli Lilly declared on September 28, 2005 that they are adding a black-box warning to its attention deficit (AD) medication ‘Strattera’. The new warning will claim that the drug increase suicidal thoughts among youths. The FDA issued a health advisory on ‘Strattera’ after evaluating … [Read more...] about Strattera Side Effects May Result In Suicide Lawsuits
ADHD drugmakers must tell of risks
Officials Told the ADHD Drugmakers To Come Up With New Pamphlets About Risk Of The Drug. Federal officials told the makers of Ritalin, Adderall, Strattera and all other drugs for treatment of attention deficit hyperactivity disorder, or ADHD, on Wednesday to come up with new pamphlets to explain the potential risks of the drugs to … [Read more...] about ADHD drugmakers must tell of risks
Government wants further ADHD drug warnings
Makers Of ADHD Drug Were Advised By The Government To Give Patients Additional Warning. The makers of Ritalin, Adderall, Strattera and other drugs treating attention-deficit hyperactivity disorder were advised by the government Wednesday to give patients and their parents an additional warning that those medicines could … [Read more...] about Government wants further ADHD drug warnings
Lilly to Add Strattera Labeling Warning
Strattera Black Box Warning. A pharmaceutical maker volunteers to add a black-box warning noting rare occurrences of suicidal thoughts in young patients taking its popular ADHD drug. Eli Lilly and Co. announced September 29 that it was complying with a request from the U.S. Food and Drug Administration (FDA) to add a "black-box" … [Read more...] about Lilly to Add Strattera Labeling Warning
A Warning to Eli Lilly With Respect to Strattera Ad
False And Misleading Eli Lilly Strattera TV Ad. In a letter to Eli Lilly, the FDA has warned the pharmaceutical giant that its television advertisement for Strattera “is false or misleading because it inadequately communicates the indication for ‘Strattera’ and minimizes the risk associated with Strattera.” broader … [Read more...] about A Warning to Eli Lilly With Respect to Strattera Ad
Strattera New Risk Label
Strattera New Risk Label. Strattera, used to treat attention-deficit hyperactivity disorder, is getting an updated label to highlight the risk the drug might contribute to severe liver problems in some patients. The government said yesterday the warning says the medication should be discontinued in patients who develop … [Read more...] about Strattera New Risk Label
